R2696 (Ramipril 5 mg)
Pill with imprint R2696 is Yellow, Capsule-shape and has been identified as Ramipril 5 mg. It is supplied by Actavis.
Ramipril is used in the treatment of high blood pressure; left ventricular dysfunction; diabetic kidney disease; heart attack; cardiovascular risk reduction (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for R2696
Ramipril
- Imprint:
- R2696
- Strength:
- 5 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis
- National Drug Code (NDC):
- 00228-2696
More about ramipril
- Ramipril Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 70 Reviews
- Drug class: Angiotensin Converting Enzyme Inhibitors
- FDA Alerts (1)
Consumer resources
Other brands: Altace
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
